0001213900-24-010227 Sample Contracts

SECURITIES PURCHASE AGREEMENT

Common Stock Purchase Agreement • February 6th, 2024 • Phoenix Biotech Acquisition Corp. • Biological products, (no disgnostic substances) • New York

• Contract Type
  Common Stock Purchase Agreement
• Filed
  February 6th, 2024
• Company
  Phoenix Biotech Acquisition Corp.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  New York

The Company shall use its best efforts to effect the registration of the Registrable Securities in accordance with the intended method of disposition thereof, and, pursuant thereto, the Company shall have the following obligations:

FIRST AMENDMENT TO BUSINESS COMBINATION AGREEMENT AND PLAN OF REORGANIZATION

Business Combination Agreement and Plan of Reorganization • February 6th, 2024 • Phoenix Biotech Acquisition Corp. • Biological products, (no disgnostic substances)

• Contract Type
  Business Combination Agreement and Plan of Reorganization
• Filed
  February 6th, 2024
• Company
  Phoenix Biotech Acquisition Corp.
• Industry
  Biological products, (no disgnostic substances)

This FIRST AMENDMENT TO BUSINESS COMBINATION AGREEMENT AND PLAN OF REORGANIZATION (this “Amendment”) is made and entered into as of February [•], 2024 by and among Phoenix Biotech Acquisition Corp., a Delaware corporation (“SPAC”), PBCE Merger Sub, Inc., a Delaware corporation and wholly-owned direct subsidiary of SPAC (“Merger Sub”), and CERo Therapeutics, Inc., a Delaware corporation (the “Company”). Unless otherwise specifically defined herein, all capitalized terms used but not defined herein shall have the meanings ascribed to them in the Agreement (as defined below).